Participants 0 105 3
Impact of antisecretory treatment on respiratory symptoms of gastroesophageal reflux disease in children.
Participants 223 409 6
Seventy-eight children presenting with typical and extraesophageal symptoms of gastroesophageal reflux disease underwent a multichannel intraluminal impedance and pH monitoring (MII/pH).
Participants 410 565 6
Children with a positive MII/pH were randomly treated with proton pump inhibitors (PPIs) or histamine H(2) -receptor antagonists (H(2) RAs) during 3 months
Participants 631 738 3
A second treatment period of 3 months was given to those patients who were not symptom-free after 3 months.
